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Type III secretion signal are examples of effector proteins that mimic the active states of N-WASP (ref. 14) or N-WASP activators such as CDC42 (ref. 15) . Previous studies have shown that EspF U interacts with the GBD (refs 16, 17) , the regulatory domain in N-WASP that participates in autoinhibition and binds to activated CDC42 (ref. 7) . Thus, we set out to test the hypothesis that EspF U may mimic an activated state of CDC42.
EspF U has a type III secretion signal followed by five-and-a-half 47-amino-acid repeats ( Fig. 1e ; a six-and-a-half-repeat isoform of EspF U has also been reported 5 ). The repeats are nearly identical and share little sequence homology with other proteins, except for the related EHEC protein EspF. EspF also activates N-WASP (ref. 18) but does not participate in pedestal formation 4, 19 (EspF contributes to the disruption of epithelial tight junctions).
We first mapped the minimal interacting fragments of both EspF U and N-WASP using pull-down-binding assays. We found that the N-WASP GBD could bind to a single EspF U repeat. We tested other truncations and found that the first 17 amino acids of each repeat constitute the minimal fragment with high affinity for the GBD (Fig. 1f and Supplementary Fig. 2 ). This sequence corresponds to a predicted a-helix 20 and it is repeated six times in the full-length protein. There are minor sequence differences among the six copies of this motif, but the repeats seem to be equivalent in binding and functional assays (data not shown).
The N-WASP GBD is a composite regulatory domain made up of two overlapping elements-a CDC42-binding element and an autoinhibitory element that binds to the C-helix 7 . Detailed mapping of the N-WASP side of the interaction showed that the carboxy-terminal, autoinhibitory portion of the GBD interacts with EspF U and that the amino-terminal, CDC42-binding portion does not. The minimal EspF U -binding fragment of N-WASP is residues 228-270 ( Fig. 1f and Supplementary Fig. 2 ), which form the core of the interaction with the C-helix in the autoinhibited structure (Fig. 2a ) 7 . Because a small peptide from EspF U interacts with the autoinhibitory portion of the GBD, it seemed unlikely that EspF U was activating N-WASP by mimicking CDC42. Instead, we postulated that this EspF U fragment might be mimicking the C-helix and disrupting N-WASP autoinhibition by competitively binding to the GBD. We found that EspF U does indeed competitively disrupt the N-WASP autoinhibitory interaction in a pull-down-binding assay (Fig. 2b) . Sequence alignment of the C-helix and the first 17 amino acids of the EspF U repeat revealed sequence homology at three positions at which hydrophobic amino acids are known to be critical for interaction with the GBD (Fig. 2a, c ) 21 . We carried out a systematic alanine scan of both the N-WASP and the EspF U fragments and tested binding of the mutants to the GBD. The results showed that mutation of any of the conserved hydrophobic positions to alanine on either the C-helix or the EspF U fragment completely disrupted interaction with the GBD (Fig. 2c) .
Previous work has shown that the isolated WASP GBD is only partially folded and unstable, but that fusion of the C-helix to the GBD leads to a stably folded, helical structure that approximates the autoinhibited state 7 . We made a fusion of the GBD to the minimal 17-amino-acid interacting fragment from EspF U found that this protein had very similar helical content and thermal stability to the GBD-C-helix fusion ( Supplementary Fig. 3 ).
These results show that the N-terminal 17 amino acids of the EspF U repeat are mimicking the C-helix (an autoinhibitory element) and this motif competitively disrupts autoinhibition of WASPs (Fig. 2d) . A similar sequence motif is present in EspF and probably activates N-WASP using the same mechanism. We found that one EspF U repeat binds to the N-WASP GBD (amino acids 214-274) with a dissociation constant (K d ) of 18 nM ( Supplementary Fig. 4 ). This affinity is about 100-fold tighter than previously measured values for the corresponding WASP GBD-C-helix interaction (in trans) 7 , and this higher affinity explains how an intermolecular interaction can competitively disrupt an intramolecular interaction. The C-helix also contributes to the interactions of N-WASP with actin monomers and the ARP2/3 complex 22 . We found that EspF U can bind to these molecules as well ( Supplementary Fig. 4 ). In spite of this, EspF U cannot stimulate actin polymerization without N-WASP (data not shown).
Utilization of a competitive autoinhibitory fragment represents a previously unknown strategy for a pathogen to use in hijacking host cell signalling. One possible advantage of this strategy is increased specificity: a constitutively active signalling mimic will activate all downstream endogenous signalling pathways, whereas a mimic of a regulatory element should only activate a small subset. To test this idea, we investigated whether EspF U could activate the p21-activated kinases (PAKs)-another group of CDC42-responsive proteins, the regulation of which is most closely related to that of WASPs. CDC42 activates PAKs by disrupting an autoinhibitory interaction (which is structurally homologous to that of WASP) 23 . However, the PAK homologue of the WASP C-helix lacks the consensus sequence of three conserved hydrophobic amino acids. EspF U was unable to activate PAKs (Fig. 2e and Supplementary Fig. 5 ), indicating specificity of EspF U towards WASP family proteins (Fig. 2d) . This more targeted activation may be advantageous for the pathogen, given the broad range of downstream effects mediated by WASP activators such as CDC42.
We also investigated the functional significance of this autoinhibitory mimic being repeated six times in one EspF U molecule. We tested the relative abilities of EspF U fragments of different lengths to stimulate actin assembly using an in vitro pyrene-actin-polymerization assay. One repeat from EspF U can disrupt the N-WASP autoinhibitory interaction in a binding assay ( Supplementary Fig. 6 ), but has low ability to stimulate actin polymerization (comparable to that of a single endogenous activator; Fig. 3a) . A fragment of two repeats EspF U residues 1-17 alanine scan: , highlighting the C-helix (green) and three critical side chains (red). b, EspF U can competitively disrupt the N-WASP autoinhibitory interaction (in trans) in a GST-pulldown assay. c, Alanine scanning mutagenesis shows a similar pattern of critical residues in the N-WASP C-helix and in EspF U (repeat 4, residues 1-17; assayed by binding to GBD in a GST-pull-down assay). d, Model comparing N-WASP activation by CDC42 and EspF U . e, PAK kinase assay showing phosphorylation of myelin basic protein (MBP). PAK2 alone is autoinhibited; CDC42 activates it, but EspF U does not.
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activity until full-length EspF U (residues 80-337, lacking the secretion signal), which has a maximal activity at the same level as unregulated N-WASP ( Fig. 3a and Supplementary Fig. 7) . To see whether this trend continued, we made an EspF U protein that has eight-and-a-half repeats and found that it reaches the same maximal activity as the wild-type protein, but is even more potent at low concentrations (Fig. 3a) . At very high concentrations, EspF U proteins had a partial inhibitory effect on actin polymerization (data not shown), probably owing to EspF U sequestering actin monomers and/or ARP2/3.
We constructed a minimized EspF U protein in which six copies of the 17-residue C-helix mimic are separated by glycine-serine linkers. This construct was still able to stimulate actin polymerization (albeit with lower potency than wild-type EspF U ), showing that the C-terminal portion of each EspF U repeat is not essential for activity (Supplementary Fig. 8 ).
Next, we tested whether multiple repeats were also required in more complex assays of actin assembly-namely a reconstituted bead motility assay and an in vivo clustering assay. In the first assay, EspF U fragments are chemically coupled to polystyrene beads; these beads are incubated with a mixture of actin and actin-regulatory proteins and are examined by microscopy for the ability to stimulate actin assembly and motility 24 . Beads coated with full-length EspF U triggered formation of an F-actin shell that breaks symmetry and induces transient polarized bead movement (Fig. 3b) . Beads coated with three EspF U repeats showed similar behaviour (albeit with a slightly more diffuse actin shell), whereas two-repeat beads formed shells that were very diffuse, showed significantly reduced actin fluorescence, and dissembled within minutes. Beads coated with a single repeat showed minimal ability to polymerize actin (Fig. 3b) . We varied the surface density of EspF U protein on the beads and found that this had little effect on the relative activities of the different fragments (data not shown). In particular, one-repeat beads had weak activity, even at maximal density. This shows that a high local concentration of a single repeat has minimal effect-multiple repeats in the same polypeptide chain are required for potent activation of actin polymerization.
To test the ability of EspF U fragments to form actin structures in cells, we used an antibody-induced clustering assay. Previous work has shown that N-WASP or N-WASP activators can form actin structures when clustered at the plasma membrane 25 . In our assay, the EspF U fragment was expressed as a fusion to the cytoplasmic tail of a transmembrane protein and then clustered using an antibody that recognizes the extracellular portion of the protein 26 . On clustering of full-length EspF U , we observed co-localization of N-WASP and bright actin foci to the clusters, showing that clustering of EspF U is sufficient to trigger localized actin assembly (Fig. 3c and Supplementary Figs 9 and 10 ). Furthermore, we tested three-, twoand one-repeat fragments and observed the same trend: three repeats showed similar activity to full-length EspF U , two repeats had intermediate activity and one repeat had lower activity (Fig. 3c) . We used a computational image analysis tool (D.V., unpublished) to detect and correlate antibody and actin clusters ( Supplementary Fig. 11 ). These quantitative results show that clustering of EspF U fragments with more repeats causes formation of actin clusters with higher frequency and intensity (Fig. 3d) .
The requirement of multiple repeats for activation of actin polymerization suggests that EspF U needs to simultaneously bind and activate multiple N-WASP proteins to be highly active. To address this, we investigated the stoichiometry of the EspF U -N-WASP complex using analytical ultracentrifugation (AUC). By AUC (data not shown) and binding assays ( Supplementary Fig. 12 ), we found that each repeat in an EspF U fragment could simultaneously bind an isolated N-WASP GBD (for example, a three-repeat fragment bound to three GBDs). However, the model in which EspF U has high potency because it can activate multiple N-WASPs does not explain why a two-repeat fragment has lowered activity in our actin assays. We found a likely answer to this question through stoichiometric analyses of complexes of a two-repeat protein with a larger, autoinhibited N-WASP construct. These AUC data showed that whereas the two-repeat fragment can bind one N-WASP easily, binding of a second is less favourable (possibly owing to steric effects) and only happens in large excess of N-WASP (Supplementary Fig. 13 ). Larger fragments of EspF U , in contrast, readily formed complexes with two or more N-WASP proteins (Supplementary Fig. 13 ). Taken with our activation data, this suggests that activity of EspF U fragments correlates with their ability to coordinate the activation of at least two N-WASP proteins (Fig. 3e ). There are a number of other cases in which oligomerization of WASPs or WASP activators leads to similarly increased activity-including the potent actin polymerization induced by glutathione S-transferase (GST)-tagged N-WASP WCA 27 (presumably owing to GST dimerization) and by oligomerized SNX9 in endocytosis 28 .
Clusters with F-actin (%) Relative F-actin intensity We have shown here that the EHEC protein EspF U has evolved a unique mechanism to potently and specifically activate N-WASPmediated actin polymerization through a repeated autoinhibitory mimic. This co-opting of a small internal regulatory unit for activation of a target protein represents a previously unknown pathogenic strategy. Furthermore, multiple repeated copies of this motif are essential for potent activity, apparently because a single EspF U protein must coordinate simultaneous activation of multiple N-WASPs.
METHODS SUMMARY
EspF U expression and purification. EspF U fragments were amplified by PCR from EHEC genomic DNA (ATCC). All cloning and expression was done in E. coli BLR(DE3) strains lacking recombinase A. Unless explicitly stated, EspF U fragments consist of the most N-terminal repeats. Pyrene-actin-polymerization assay. ARP2/3 was purified from bovine brain, and actin was purified from rabbit muscle and pyrene-labelled, as described previously 29 . Actin polymerization was monitored as an increase in pyrene-actin fluorescence. Raw fluorescence data were normalized to the lower and upper baselines of each curve. Relative activities of EspF U fragments were determined through calculation of the time required to reach half-maximal fluorescence (t 1/2 ). Bead motility assay. Actin and ARP2/3 were purified from Acanthamoeba castellanii, as described previously 30 . EspF U proteins were coupled to polystyrene beads and mixed with actin, ARP2/3, N-WASP, capping protein and profilin. The assay was adapted from a protocol developed in ref. 24 . Images were acquired with a Nikon TE300 Eclipse inverted epifluorescence microscope with constant imaging settings between experiments. In vivo clustering experiments. NIH 3T3 fibroblasts were co-transfected with actin-GFP (green fluorescent protein) and the corresponding CD16/7 fusion construct. Cells were treated with clustering antibodies, as described previously 26 . Fixed cells were imaged with an oil-immersion 360 NA 1.4 objective on a Zeiss LSM 510 Meta microscope. Imaging settings were constant between experiments, except for minor adjustments of detector gain to accommodate variation in expression level.
Quantitative detection of clusters was performed with a computational tool developed by D. Vasilescu. Ten cell images from three independent experiments were quantified for each construct. Data were presented in two metrics: the percentage of antibody clusters that have associated actin clusters and the intensities of these associated actin clusters. The relative intensity value is the ratio of the sum of intensities of associated actin clusters to the sum of intensities of all antibody clusters.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Protein construction and purification. Because of the high DNA sequence conservation between EspF U repeats, PCR reactions would result in a ladder of bands on a gel that corresponded to 1 repeat, 2 repeats, and so on. We made repeat fragments by cutting out the bands that corresponded to 1 repeat up to 5 repeats. EspF U proteins were expressed as N-terminal hexahistidine (pET19-derived vector) or GST (pGEX4T-1 vector) fusions and purified on Ni-NTA resin (Qiagen) or glutathione agarose (Sigma), respectively. Proteins were further purified by ion exchange chromatography on a Source Q column (Pharmacia).
The synthetic eight-and-a-half-repeat EspF U protein was assembled through introduction of a silent AatII restriction site near the N terminus of the repeat. By PCR, we made one three-repeat fragment starting at the N terminus of EspF U and ending with the AatII site, and a second five-and-a-half-repeat fragment starting with the AatII site and ending at the C terminus of EspF U . These two fragments were cut with AatII (NEB) and ligated to form the eight-and-a-halfrepeat protein.
The two WASP family proteins used in this study are human WASP (referred to as 'WASP') and rat neuronal WASP (referred to as 'N-WASP'). Mini N-WASP
